{"id":"W2913731987","doi":"10.1093/ecco-jcc/jjy222.841","title":"P717 The use of combination biologic therapy in inflammatory bowel disease: A single tertiary-centre experience","year":2019,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Microscopic Colitis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Vedolizumab; Medicine; Infliximab; Golimumab; Adalimumab; Ustekinumab; Inflammatory bowel disease; Internal medicine; Ulcerative colitis; Crohn's disease; Faecal calprotectin; Combination therapy; Certolizumab pegol; Refractory (planetary science); Biologic Agents; Oncology; Disease; Calprotectin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007205572,0.0004356811,0.000571972,0.0005735242,0.001195481,0.001203824,0.0006192558,0.0006749549,0.003559558],"category_scores_gemma":[0.002244762,0.0003928564,0.0006240506,0.001160765,0.0006024233,0.0005693343,0.00118188,0.0009164342,0.001049378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001081463,"about_ca_system_score_gemma":0.001193782,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002288638,"about_ca_topic_score_gemma":0.004039079,"domain_scores_codex":[0.999029,0.0002862289,0.0001007808,0.0001596451,0.0002164946,0.0002078603],"domain_scores_gemma":[0.9977598,0.0004271689,0.0004912836,0.0001657936,0.0001758303,0.0009801512],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002607965,0.004282615,0.7598288,0.0005928349,0.0002958965,0.06301869,0.006276588,0.0006764578,0.0101647,0.0003327231,0.003034375,0.1488883],"study_design_scores_gemma":[0.000682215,0.02647452,0.7541253,0.0003915185,0.0003282845,0.1951561,0.005433449,0.001438956,0.003633668,0.0002433088,0.01195736,0.0001353299],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949102,0.001800613,0.0004943406,0.0002254201,0.00002189322,0.00007345086,0.00007221597,0.00001886876,0.002382999],"genre_scores_gemma":[0.9969773,0.001450171,0.0004848105,0.0002372392,0.00007671007,0.0000282381,0.0001184469,0.00001558569,0.0006114629],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003559558,"threshold_uncertainty_score":0.01190794,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0208786017046452,"score_gpt":0.2619716559319216,"score_spread":0.2410930542272764,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}